Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)

NCT04826588 is registered in ClinicalTrials.gov with University Children's Hospital Basel as lead sponsor.

NCT NCT04826588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04826588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)
Lead sponsor
University Children's Hospital Basel
Phase
Phase 3
Overall status
Completed
Start date
May 23, 2021
Completion date
November 20, 2022
Enrollment
76 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

paediatric inflammatory multisystem syndrome-temporally associated with sars-cov-2 (pims-ts)